S. Khosla et al., EFFECTS OF AGE AND ESTROGEN STATUS ON SERUM PARATHYROID-HORMONE LEVELS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN WOMEN - A POPULATION-BASED STUDY, The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1522-1527
Although estrogen deficiency is responsible far the increase in bone t
urnover in early postmenopausal women, age-related factors, such as th
e progressive increase in serum PTH levels, are believed to be respons
ible for the increase in bone turnover in elderly women. Whether estro
gen deficiency continues to play a role, either directly or indirectly
, in the pathogenesis of the increased bone turnover in elderly women
remains unclear. Thus, we measured serum PTH, markers of bane turnover
, and serum sex steroid levels in a population-based sample of 351 wom
en (age range, 21-94 yr), which included 47 postmenopausal women who m
ere receiving long term estrogen replacement therapy. Serum PTH increa
sed as a function of age when the premenopausal women and the estrogen
-deficient postmenopausal women were analyzed together (r = 0.35; P <
0.001). By contrast, this age-related increase in serum PTH was elimin
ated in the postmenopausal women receiving long term estrogen therapy,
which also resulted in a similar suppression of markers of bone forma
tion and resorption in bath the early (less than or equal to 20 yr) an
d late (>20 yr) postmenopausal women. By multivariate analysis, serum
25-hydroxyvitamin D levels were highly predictive of serum PTH levels
regardless of menopausal status, whereas serum estrone levels were pre
dictive of markers of bone resorption in the postmenopausal women. We
conclude that estrogen deficiency may be responsible not only for the
increase in bone turnover in early postmenopausal women, but also indi
rectly for the secondary hyperparathyroidism and increase in bone turn
over found in late postmenopausal women. Residual serum estrogen level
s are important determinants of bone resorption in postmenopausal wome
n.